COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Authors:
- 8 February 2022
- journal article
- editorial
- Published by Elsevier in The Lancet Rheumatology
- Vol. 4 (4) , e237-e240
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseasesVaccine, 2021
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine SurveyRMD Open, 2021
- Understanding COVID-19 vaccine hesitancyNature Medicine, 2021
- Patients With Acute Myocarditis Following mRNA COVID-19 VaccinationJAMA Cardiology, 2021
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?The Lancet, 2021
- Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseasesThe Lancet Rheumatology, 2021
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1Arthritis & Rheumatology, 2021
- Evidence-Based Strategies for Clinical Organizations to Address COVID-19 Vaccine HesitancyMayo Clinic Proceedings, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020